Cabazitaxel MSN 60 mg concentrate and solvent for solution for infusion Irland - engelsk - HPRA (Health Products Regulatory Authority)

cabazitaxel msn 60 mg concentrate and solvent for solution for infusion

msn labs europe limited - cabazitaxel - concentrate and solvent for solution for infusion - cabazitaxel

Cabazitaxel 10 mg/ml concentrate for solution for infusion Irland - engelsk - HPRA (Health Products Regulatory Authority)

cabazitaxel 10 mg/ml concentrate for solution for infusion

teva b.v. - cabazitaxel 2-propanol solvate - concentrate for solution for infusion - cabazitaxel

Cabazitaxel Teva 10 mg/ml Concentrate for solution for infusion Irland - engelsk - HPRA (Health Products Regulatory Authority)

cabazitaxel teva 10 mg/ml concentrate for solution for infusion

teva b.v. - cabazitaxel - concentrate for solution for infusion - 10 milligram(s)/millilitre - cabazitaxel

Cabazitaxel Fresenius Kabi 20 mg/ml concentrate for solution for infusion Irland - engelsk - HPRA (Health Products Regulatory Authority)

cabazitaxel fresenius kabi 20 mg/ml concentrate for solution for infusion

fresenius kabi deutschland gmbh - cabazitaxel - concentrate for solution for infusion - cabazitaxel

CABAZITAXEL-REDDY'S cabazitaxel 60 mg/1.5 mL concentrated injection vial Australia - engelsk - Department of Health (Therapeutic Goods Administration)

cabazitaxel-reddy's cabazitaxel 60 mg/1.5 ml concentrated injection vial

dr reddys laboratories australia pty ltd - cabazitaxel, quantity: 60 mg - injection, concentrated - excipient ingredients: citric acid; polysorbate 80 - cabazitaxel-reddy?s in combination with prednisone or prednisolone is indicated for the treatment of patients with metastatic castration resistant prostate cancer previously treated with a docetaxel containing regimen.

CABAZITAXEL-DRLA cabazitaxel 60 mg/1.5 mL concentrated injection vial Australia - engelsk - Department of Health (Therapeutic Goods Administration)

cabazitaxel-drla cabazitaxel 60 mg/1.5 ml concentrated injection vial

dr reddys laboratories australia pty ltd - cabazitaxel, quantity: 60 mg - injection, concentrated - excipient ingredients: citric acid; polysorbate 80 - cabazitaxel-drla in combination with prednisone or prednisolone is indicated for the treatment of patients with metastatic castration resistant prostate cancer previously treated with a docetaxel containing regimen.

CABAZITAXEL S.K. Israel - engelsk - Ministry of Health

cabazitaxel s.k.

k.s.kim international (sk- pharma) ltd., israel - cabazitaxel - concentrate and solvent for solution for infusion - cabazitaxel 40 mg/ml - cabazitaxel - cabazitaxel s.k. is indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer previously treated with a docetaxel- containing treatment regimen.

CABAZITAXEL INTAS cabazitaxel 60 mg/3 mL concentrated injection vial Australia - engelsk - Department of Health (Therapeutic Goods Administration)

cabazitaxel intas cabazitaxel 60 mg/3 ml concentrated injection vial

accord healthcare pty ltd - cabazitaxel, quantity: 60 mg - injection, concentrated - excipient ingredients: polysorbate 80; ethanol absolute - cabazitaxel intas in combination with prednisone or prednisolone is indicated for the treatment of patients with metastatic castration resistant prostate cancer previously treated with a docetaxel containing regimen. .

CABAZITAXEL SANDOZ cabazitaxel (as monohydrate) 45 mg/4.5 mL concentrated injection vial Australia - engelsk - Department of Health (Therapeutic Goods Administration)

cabazitaxel sandoz cabazitaxel (as monohydrate) 45 mg/4.5 ml concentrated injection vial

sandoz pty ltd - cabazitaxel, quantity: 45 mg - injection, concentrated - excipient ingredients: citric acid; ethanol absolute; polysorbate 80; macrogol 300 - cabazitaxel sandoz in combination with prednisone or prednisolone is indicated for the treatment of patients with metastatic castration resistant prostate cancer previously treated with a docetaxel containing regimen.

CABAZITAXEL SANDOZ cabazitaxel (as monohydrate) 60 mg/6 mL concentrated injection vial Australia - engelsk - Department of Health (Therapeutic Goods Administration)

cabazitaxel sandoz cabazitaxel (as monohydrate) 60 mg/6 ml concentrated injection vial

sandoz pty ltd - cabazitaxel, quantity: 60 mg - injection, concentrated - excipient ingredients: citric acid; ethanol absolute; macrogol 300; polysorbate 80 - cabazitaxel sandoz in combination with prednisone or prednisolone is indicated for the treatment of patients with metastatic astration resistant prostate cancer previously treated with a docetaxel containing regimen.